US: Roos shut down following listeria-death link
The US Food and Drugs Administration has shut down the Roos Foods Inc cheese production facility following a listeria outbreak in which one person died and seven were hospitalised.
The "suspension" was ordered on 11 March following an investigation which "determined there was a reasonable probability of food manufactured, processed, packed, or held by Roos Foods causing serious adverse health consequences or death to humans," the body said in a statement.
The facility was inspected by the FDA between 18 February and 4 March 2014. Investigators claimed to find "insanitary conditions".
The FDA said:
- "The roof leaking so badly that water was raining down into the cheese processing room, including onto the cheese processing equipment and storage tanks;
- standing water on the floor throughout the cheese curd processing room in proximity to the cheese vats and in the storage rooms;
- metal roof/ceiling and metal supports exhibiting a rusted appearance with metal flaking precluding effective cleaning and sanitizing;
- food residues found on equipment after cleaning had been performed;
- openings to milk storage tanks and transfer piping were not capped to prevent contaminants from entering or contaminating food contact surfaces; and
- floors, wall, and equipment that were deteriorated and in bad repair, including processing equipment and storage vats with rust holes and floors with rough concrete deterioration."
A swab-test on different areas of the facility found 12 that tested positive for Listeria monocytogenes, 11 of which carried the same "DNA-fingerprint" as the outbreak strain.
No-one at Roos Foods was available for comment when approached by just-food.
- Nestle on China, candy, nutrition - analysis
- Why Jet.com purchase could boost Wal-Mart online
- Interview, part 1: Emmi CEO Urs Riedener
- What lies ahead for Tyrrells and Amplify?
- Murray Goulburn's FY results - 7 things to learn
- Mondelez buys rest of Vietnam snacks business
- Australia launches dairy sector probe
- Smucker cuts forecast as sales decline
- Emmi earnings grow but sales outlook lowered
- Tyson faces investor scrutiny on ethical issues